The CD47 protein is highly expressed in many types of cancer, including acute and chronic myeloid leukemia, non-Hodgkin lymphomas, multiple myeloma, leiomyosarcoma, glioblastoma, and bladder, ovarian, prostate, breast, and colon carcinomas. Here, CD47 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.